After careful study, Qingdao Haier Biomedical Co., Ltd. decided to terminate the planning of this major asset restructuring, and the Company's stock trading will be resumed from the opening of the market on January 7, 2025.
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment